A caution: please do not discuss politics per se here. Judging from the PMs I get, there are many opinions. As far as how any changes in health care coverage will affect Kevetrin, I think it is too early even to speculate. We don't know what is going to happen in the next months and years, but consider this:

if Kevetrin works as we hope it will, it will be CHEAPER to treat people with Kevetrin either by itself or as an adjunct (co-therapy) -- because if it makes treatment more effective with fewer side effects, it means fewer procedures and therefore lots of cost savings.

So I think we need to wait until we find out what the clinical trial results are before we speculate as to what impact, if any, that changes in insurance will cause.